Repro-Med Systems, Inc. (OTCMKTS:REPR) Director Joseph M. Jr. Manko bought 222,710 shares of the stock in a transaction on Tuesday, November 28th. The shares were purchased at an average price of $0.80 per share, with a total value of $178,168.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.

Repro-Med Systems, Inc. (OTCMKTS REPR) traded down $0.02 during trading on Friday, hitting $0.84. 23,401 shares of the stock were exchanged, compared to its average volume of 47,130. Repro-Med Systems, Inc. has a one year low of $0.34 and a one year high of $0.83. The firm has a market cap of $30.34, a P/E ratio of 80.00 and a beta of -0.55.

COPYRIGHT VIOLATION NOTICE: This news story was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this news story on another domain, it was stolen and republished in violation of US and international trademark & copyright law. The original version of this news story can be accessed at

About Repro-Med Systems

REPRO MED SYSTEMS, INC. (RMS) designs, manufactures and markets medical devices for the ambulatory infusion market and emergency medical applications. The Company’s products include FREEDOM60 Syringe Infusion System (FREEDOM60), RMS HIGH-Flo Subcutaneous Safety Needle Sets (HIgH-Flo), RES-Q-VAC Portable Medical Suction System (RES-Q-VAC) and On-Line Calculator.

Insider Buying and Selling by Quarter for Repro-Med Systems (OTCMKTS:REPR)

Receive News & Ratings for Repro-Med Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Repro-Med Systems Inc. and related companies with's FREE daily email newsletter.